CELLECTIS S A's ticker is CLLS and the CUSIP is 15117K103. A total of 51 filers reported holding CELLECTIS S A in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $57,900 | +96.9% | 30,000 | +114.3% | 0.00% | – |
| Q4 2022 | $29,400 | -8.1% | 14,000 | 0.0% | 0.00% | – |
| Q3 2022 | $32,000 | -20.0% | 14,000 | 0.0% | 0.00% | – |
| Q2 2022 | $40,000 | -37.5% | 14,000 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $64,000 | -43.9% | 14,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $114,000 | -90.7% | 14,000 | -85.6% | 0.00% | -90.9% |
| Q3 2021 | $1,226,000 | -20.2% | 97,213 | -2.1% | 0.01% | -15.4% |
| Q2 2021 | $1,536,000 | -12.9% | 99,295 | +13.8% | 0.01% | 0.0% |
| Q1 2021 | $1,763,000 | -62.5% | 87,216 | -49.8% | 0.01% | -13.3% |
| Q4 2020 | $4,698,000 | – | 173,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Long Focus Capital Management, LLC | 4,487,293 | $7,089,923 | 0.25% |
| OPPENHEIMER & CO INC | 121,420 | $191,844 | 0.00% |
| CREDIT SUISSE AG/ | 1,438,255 | $2,272,443 | 0.00% |
| Baillie Gifford | 1,164,009 | $1,839,135 | 0.00% |
| PRINCIPAL FINANCIAL GROUP INC | 656,600 | $1,037,428 | 0.00% |
| Capital International Investors | 1,848,804 | $2,921,110 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,095,966 | $1,731,626 | 0.00% |
| EverSource Wealth Advisors, LLC | 13 | $21 | 0.00% |
| Qube Research & Technologies Ltd | 40 | $63 | 0.00% |
| Tower Research Capital LLC (TRC) | 111 | $175 | 0.00% |